A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

November 30, 2026

Conditions
Gynecological Tumors
Interventions
DRUG

TQB2102 for injection

TQB2102 for injection is a HER2 dual-antibody-drug Conjugate (ADC).

Trial Locations (31)

53000

NOT_YET_RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

63000

NOT_YET_RECRUITING

Tangshan People's Hospital, Tangshan

100021

NOT_YET_RECRUITING

Cancer Hospital Chinise Academy of Medical Sciences, Beijing

110044

NOT_YET_RECRUITING

Liaoning Cancer Hospital, Shenyang

130012

NOT_YET_RECRUITING

Jilin Cancer Hospital, Changchun

130021

NOT_YET_RECRUITING

Jilin Provincial People's Hospital, Changchun

135000

NOT_YET_RECRUITING

Meihekou Central Hospital, Meihekou

150040

NOT_YET_RECRUITING

Harbin Medical University Cancer Hostipal, Harbin

200025

NOT_YET_RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Med, Shanghai

200032

NOT_YET_RECRUITING

Fudan University Shanghai Cancer center, Shanghai

200090

NOT_YET_RECRUITING

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

300060

NOT_YET_RECRUITING

Tianjin Medical University Cancer Hospital, Tianjin

310022

NOT_YET_RECRUITING

ZheJiang Cancer Hospital, Hangzhou

330077

NOT_YET_RECRUITING

Jiangxi Maternal and Child Health Hospital, Nanchang

350000

NOT_YET_RECRUITING

Fujian Provincial Maternal and Child Health Hospital, Fuzhou

350014

RECRUITING

Fujian Cancer Hospital, Fuzhou

400030

NOT_YET_RECRUITING

Chongqing University Cancer Hospital, Chongqing

410013

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

430000

NOT_YET_RECRUITING

Tongji Medical College of Huazhong University of Science and Technology, Wuhan

450000

NOT_YET_RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

450014

NOT_YET_RECRUITING

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

510060

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

510623

NOT_YET_RECRUITING

Guangzhou Women and Children's Medical Center, Guangzhou

511518

RECRUITING

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital, Qingyuan

NOT_YET_RECRUITING

Affiliated Qingyuan Hospital,Guangzhou Medical University,Qingyuan People's Hospital, Qingyuan

514000

NOT_YET_RECRUITING

Meizhou peoples Hospital, Meizhou

610041

NOT_YET_RECRUITING

West China Second Hospital of Sichuan University, Chengdu

710000

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an

730050

NOT_YET_RECRUITING

GanSu Cancer Hospital, Lanzhou

830011

NOT_YET_RECRUITING

Xinjiang Medical University Affiliated Cancer Hospital, Ürümqi

050000

NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY